Susquehanna options strategist Alison Edwards notes bullish options positioning in Gilead Sciences (NASDAQ: GILD), as an opening investor bought 10,000 Mar 85 Calls for $2.20

Options Trader Talk

Gilead Sciences' (GILD) BIKTARVY Receives FDA ApprovalFebruary 7, 2018 2:11 PM Gilead Sciences (GILD) PT Lowered to $84 at Morgan StanleyFebruary 7, 2018 8:06 AM Gilead Sciences (GILD) PT Lowered to $83 at Leerink PartnersFebruary 7, 2018 7:10 AM Gilead Sciences (GILD) PT Raised to $80 at UBSFebruary 7, 2018 6:30 AM Gilead Sciences (GILD) PT Lowered to $90 at Deutsche BankFebruary 7, 2018 6:02 AM Gilead Sciences (GILD) PT Raised to $105 at CitiFebruary 7, 2018 5:51 AM Gilead Sciences (GILD) Raises Quarterly Dividend 9.6% to $0.57; 2.8% YieldFebruary 6, 2018 4:04 PM Gilead Sciences (GILD) Q4 Revenue Tops Views, Offers GuidanceFebruary 6, 2018 4:03 PM